首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12659篇
  免费   913篇
  国内免费   34篇
耳鼻咽喉   102篇
儿科学   426篇
妇产科学   233篇
基础医学   2102篇
口腔科学   293篇
临床医学   1227篇
内科学   2232篇
皮肤病学   538篇
神经病学   1439篇
特种医学   505篇
外科学   1349篇
综合类   101篇
一般理论   11篇
预防医学   931篇
眼科学   174篇
药学   849篇
中国医学   10篇
肿瘤学   1084篇
  2023年   119篇
  2022年   185篇
  2021年   400篇
  2020年   269篇
  2019年   328篇
  2018年   384篇
  2017年   323篇
  2016年   388篇
  2015年   365篇
  2014年   488篇
  2013年   603篇
  2012年   888篇
  2011年   828篇
  2010年   436篇
  2009年   444篇
  2008年   669篇
  2007年   671篇
  2006年   643篇
  2005年   588篇
  2004年   542篇
  2003年   480篇
  2002年   476篇
  2001年   294篇
  2000年   246篇
  1999年   211篇
  1998年   122篇
  1997年   82篇
  1996年   66篇
  1995年   79篇
  1994年   71篇
  1993年   88篇
  1992年   114篇
  1991年   109篇
  1990年   121篇
  1989年   103篇
  1988年   97篇
  1987年   83篇
  1986年   88篇
  1985年   86篇
  1984年   78篇
  1983年   63篇
  1982年   52篇
  1981年   52篇
  1980年   43篇
  1979年   73篇
  1978年   45篇
  1977年   49篇
  1974年   41篇
  1973年   54篇
  1968年   43篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Collagens are the most abundant proteins in the extracellular matrix. They provide a framework to build organs and tissues and give structural support to make them resistant to mechanical load and forces. Several intra‐ and extracellular modifications are needed to make functional collagen molecules, intracellular post‐translational modifications of proline and lysine residues having key roles in this. In this article, we provide a review on the enzymes responsible for the proline and lysine modifications, that is collagen prolyl 4‐hydroxylases, 3‐hydroxylases and lysyl hydroxylases, and discuss their biological functions and involvement in diseases.  相似文献   
2.
3.
4.
5.
6.
7.
8.
9.
Decreases in sex hormone levels with menopause may bring about a number of consequences in women's general health and sexual well-being, especially when levels decline suddenly and prematurely, as in surgical menopause. In addition to the well-established role of estrogens in preserving the biological basis of sexual response, there is emerging evidence that androgens are significant independent determinants affecting sexual desire, activity and satisfaction, as well as mood, energy and other components of women's health. Hypoactive sexual desire disorder (HSDD), a persistent absence of sexual fantasies or thoughts and/or desire for and receptivity to sexual activity that causes personal distress, is experienced by some postmenopausal women. Even though conventional hormone therapy with estrogens or estrogens and progestogens may be effective for vaginal atrophy, increasing vaginal lubrication and reducing dyspareunia, it has not been shown to consistently increase sexual desire or activity and many women with sexual dysfunction remain unresponsive. Several recent, large, phase III studies have shown that the addition of transdermal testosterone to conventional hormone therapy can be helpful in surgically menopausal women presenting with HSDD. After 24 weeks of treatment in these studies, testosterone-treated women experienced significantly greater increases in satisfying sexual activity and sexual desire, and greater decreases in distress, than placebo-treated women. Accurate clinical assessment and individualized management of sexual symptoms are fundamentally important for all menopausal women with HSDD or other sexual problems.  相似文献   
10.
In 41 patients with recurrent sustained ventricular tachycardia and/or ventricular fibrillation an integrated pacemaker-defibrillator-system (PCD, Medtronic, model 7216 A or 7217 B) was implanted. In 21 out of 24 (88%) patients a new transvenous implantation technique in combination with a subcutaneous patch electrode was used. The implanted devices comprise antibradycardiac pacemaker functions, two different forms of antitachycardiac pacemaker functions (ramp and burst pacing), and internal cardioversion or defibrillation capabilities. During a mean follow-up of 8 months 147 episodes of ventricular tachycardia were detected, 131 of them were terminated successfully by antitachycardiac pacing; in 13 episodes internal cardioversion was applied to revert ventricular tachycardia. Twenty-seven episodes of ventricular fibrillation or rapid ventricular tachycardia (greater than 200/min) were detected and successfully terminated by internal defibrillation. In six patients with intermittent rapid atrial fibrillation, change of antiarrhythmic therapy was required to avoid activation of the device. The new integrated pacemaker-defibrillator systems improve therapy in patients with life-threatening tachyarrhythmias by reducing the number of internal cardioversions/defibrillations; the non-thoracotomy approach reduces the post operative risk.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号